Eloctate 1000 Unit (Antihemophilic Factor (Recombinant Bdd), Fc Fusion Protein KIT) 1000 UNIT

ELOCTATE 1000 UNIT is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous kit helps manage bleeding episodes and prevent complications. Learn more about this essential medication.

Strength

1000 UNIT

Pack Size

3ML

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ELOCTATE 1000 UNIT is primarily used for the treatment of hemophilia B, a genetic disorder that impairs blood clotting. It is designed to replace the missing clotting factor IX, which is crucial for controlling bleeding episodes. This medication is often used to prevent bleeding in individuals with hemophilia B, especially during surgeries or dental procedures. Understanding what is ELOCTATE used for can help patients manage their condition effectively.

Side Effects

Common effects of ELOCTATE 1000 UNIT may include mild reactions at the injection site, such as redness or swelling. Some users might experience headache, nausea, or dizziness. These effects are generally mild and temporary. Severe allergic reactions are rare but require immediate medical attention.

Precautions & Warnings

ELOCTATE 1000 UNIT should be handled with care and stored as per the manufacturer's instructions. It is essential to use this medication under the supervision of a healthcare professional. Patients should inform their doctor about any allergies or pre-existing conditions before starting treatment. Proper administration techniques should be followed to minimize the risk of complications.

Avoid Interactions

ELOCTATE 1000 UNIT may interact with certain medications, including other blood thinners or clotting agents. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances that affect blood clotting should be avoided unless approved by a doctor.

Frequently Asked Questions

ELOCTATE is used to treat and prevent bleeding episodes in individuals with hemophilia B.

ELOCTATE is administered intravenously, typically by a healthcare professional.

Common side effects may include mild reactions at the injection site, headache, nausea, or dizziness.

Yes, ELOCTATE can be used to manage bleeding during surgical procedures in patients with hemophilia B.

Long-term use of ELOCTATE should be monitored by a healthcare professional to ensure safety and effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.